Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,255.40 +0.88%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.66 billion.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA maintains underperform ratings on six BDC stocks
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
